J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need - The New York Times
A crucial Johnson & Johnson plant has stopped making its Covid vaccine, though the company says it has millions of doses in inventory.
He said the company was continuing to deliver batches of the vaccine to facilities that bottled and packaged doses. He also said Johnson & Johnson had millions of finished doses in inventory.
Jo… [+1802 chars]
Read More
Other Stories in Business
- Senco Gold QIP Opens To Raise Rs 500 Crore
- Brokerage Views: Goldman Sachs On DMart, Morgan Stanley On Zomato, CLSA On Cement Industry And More
- Correction In RIL, Tata Motors Led To Sharp Spike In Their Futures Open Interest
- Indian Capital Market - A Golden Era: Motilal Oswal
- Swiggy Growth Headroom, Profitability Prompt 'Outperform' Rating From CLSA On Initiation
- Intra-Cellular Therapies (ITCI): Parkinson's Disease Drug Expansion Could Be The Next Move
- Juan Soto’s $765M deal with the Mets is the largest in MLB history. Here’s who he passed
- Trump nominates ex-ambassador to Mexico to serve as deputy secretary of State
- Complete Berachain Airdrop Guide: Get Free Tokens
